Epigenomics Deal Gives Roche Access To DNA Methylation Cancer Tests
This article was originally published in The Gray Sheet
Executive SummaryRoche can expect to have DNA methylation-based cancer screening assays available to reference labs by 2006 under a collaboration with Epigenomics
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.